Essentially, all drug manufacturers are engaging in continued clinical trials to confirm the efficacy and unique value of their GLP-1 formulations
doi:10.1074/jbc.M109.067017, PMID: 20498365 Tavazzi B, Amorini AM, Fazzina G, Di Pierro D, Tuttobene M, Giardina B, Lazzarino G (2001) Oxidative stress induces impairment of human erythrocyte energy metabolism through the oxygen radical-mediated direct activation of AMP-deaminase
Malignancies in prader-willi syndrome: results from a large international cohort and literature review
Everything that's coming out, Mike, so far is an improvement in health outcomes, generally driven by weight loss, by reduction in inflammation, the ectopic fat in the muscle and in the heart and in the pancreas and in the liver